Background Fibroblast growth factor receptor 1 (FGFR1) is frequently dysregulated in various tumors. FGFR inhibitors have shown promising therapeutic ......
Peng, R; Chen, Y; Wei, LN; Li, G; Feng, DJ; Liu, SR; Jiang, RQ; Zheng, SJ; Chen, Y
Chen, Y (corresponding author), Nanjing Med Univ, Jiangsu Inst Canc Res, Res Ctr Clin Oncol, Dept Gen Surg,Affiliated Canc Hosp,Jiangsu Canc H, Nanjing 210009, Jiangsu, Peoples R China.; Zheng, SJ (corresponding author), Hainan Med Univ, Affiliated Hosp 1, Minist Educ, Key Lab Emergency & Trauma,Tumor Inst, Haikou 571199, Hainan, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Dept Immunol, Key Lab Immune Microenvironm & Dis, Nanjing 211166, Jiangsu, Peoples R China.; Jiang, RQ (corresponding author), Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing 210093, Jiangsu, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China.
GASTRIC CANCER, 2020; 23 (6): 988